AMAL Therapeutics SA - Ownership and Business Overview

Life ScienceCompany

AMAL Therapeutics SA Ownership

Who owns AMAL Therapeutics SA?

AMAL Therapeutics SA is owned by Boehringer Ingelheim. It was acquired on July 15, 2019.

AMAL Therapeutics SA Business Overview

Where is AMAL Therapeutics SA headquartered?

AMAL Therapeutics SA is headquartered in Geneve, Switzerland.

What sector is AMAL Therapeutics SA in?

AMAL Therapeutics SA is a life science company.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Join Mergr to view all 249 acquisitions of life science companies in 2019, including 44 acquisitions by private equity firms, and 205 by strategics.

AMAL Therapeutics SA

Avenue de la Roseraie 64,
Geneve, 1205
Switzerland,
+41 22 379 46 88
www.amaltherapeutics.com

AMAL Therapeutics SA is a private Swiss biotechnology company focused on cancer immunotherapy and advancing first-in-class therapeutic cancer vaccines derived from its technology platform KISIMA. AMAL Therapeutics is based in Geneve, Switzerland.


 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for AMAL Therapeutics SA

Life Science Companies , Switzerland Companies